Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection
Open Access
- 19 October 2018
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 18 (1) , 1-10
Abstract
This study aimed to evaluate the efficacy of combinations of steroidal alkaloids and conessine from the Thai medicinal plant Holarrhena antidysenterica with antibiotics against Pseudomonas aeruginosa strains possessing different efflux-pump-mediated multidrug-resistant (MDR) phenotypes in a Galleria mellonella infection model. P. aeruginosa strains with defined mutations that result in the overexpression of the MexAB-OprM, MexCD-OprJ and MexEF-OprN efflux pumps, and a strain with all three of these pumps deleted, were used. In vitro, the effect of combinations of steroidal alkaloids and conessine with antibiotics was compared with antibiotic treatment alone via MIC determination and time-kill assays. Efficacy of combinations of the steroidal alkaloids and conessine with levofloxacin were compared with monotherapies against infections in G. mellonella larvae by measuring larval mortality and bacterial burden. Combination therapies of conessine or steroidal alkaloids with levofloxacin enhanced bacterial inhibition in vitro and restored antibiotic efficacy in vivo compared to the constituent monotherapies. Neither conessine nor the steroidal alkaloids induced any detectable toxicity in G. mellonella larvae. The enhanced efficacy of the combination treatments was most pronounced with conessine and correlated with reduced larval burden of infecting P. aeruginosa. Notably, the enhanced efficacy of conessine/levofloxacin combinations was only detected in the parent strain and strains that overexpressed the MexAB-OprM or MexEF-OprN efflux systems. Steroidal alkaloids from Holarrhena antidysenterica, and particularly the principal active ingredient conessine, restored levofloxacin efficacy against resistant P. aeruginosa strains possessing efflux-mediated MDR phenotypes. The compounds should be investigated further as a potential novel therapy.Keywords
Funding Information
- Thailand Research Fund (PHD/0041/2556, RTA 5880005)
This publication has 28 references indexed in Scilit:
- Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infectionsBMC Complementary and Alternative Medicine, 2012
- Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 2011
- Pseudomonas Aeruginosa: Resistance to the MaxFrontiers in Microbiology, 2011
- Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteriaJournal of Antimicrobial Chemotherapy, 2010
- Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance MechanismsClinical Microbiology Reviews, 2009
- AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2008
- Steroidal Alkaloids from Holarrhena antidysenterica (L.) WALL.Chemical and Pharmaceutical Bulletin, 2007
- Bacterial efflux pump inhibitors from natural sourcesJournal of Antimicrobial Chemotherapy, 2006
- Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in BacteriaClinical Microbiology Reviews, 2006
- The logrank testBMJ, 2004